4UP-20962-32156
3 vaccinations
2 coded responses
28 check-ins
2 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 857 / AZ
- Registered
- 2021-01-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-10
Registered in v-safe
-
2021-01-10
Dose 1 — Moderna
- 2021-01-10
- 2021-01-11
-
2021-01-12
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain, Swelling · Chills, Muscle or body aches, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-12
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-19
- 2021-01-24
- 2021-01-31
-
2021-02-07
Dose 2 — Moderna
-
2021-02-07
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2021-02-08
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-09
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · HeadacheAdult check-in
- 2021-02-10
-
2021-02-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-02-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Itching · NoneAdult check-in
- 2021-02-14
- 2021-02-21
- 2021-02-28
- 2021-03-07
-
2021-03-14
Survey response — day 35, dose 2MedDRA: Balance disorder, Exposure to SARS-CoV-2, Hypoacusis, Labyrinthitis — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: This may not be related, but I've had labyrinthitis since about 2 weeks after my first dose. I've lost 75% functioning in my left ear (balance and hearing) and it's irreversible. One week after my first dose I was exposed to COVID.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-14
Report sent to call center — day 35, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-21
-
2021-05-09
Survey response — 3 months, dose 2MedDRA: Deafness, Vestibular disorder — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I've experienced vestibular and hearing loss in my right ear (previously only left was affected). I have reported this as a possible adverse event due to the timingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-09
Report sent to call center — 3 months, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-09
- 2021-08-08
-
2021-09-11
Dose 3 — Moderna
- 2021-10-26
- 2021-12-11
- 2022-03-12
- 2022-09-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-10 | Moderna | |
| 2 | 2021-02-07 | Moderna | |
| 3 | 2021-09-11 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-12 | priority 2/3 | |
| 2021-03-14 | Unsuccessful | |
| 2021-05-09 | Unsuccessful |
Free text
Release 5 — day 35, dose 2
Symptoms: This may not be related, but I've had labyrinthitis since about 2 weeks after my first dose. I've lost 75% functioning in my left ear (balance and hearing) and it's irreversible. One week after my first dose I was exposed to COVID.
Release 8 — 3 months, dose 2
Symptoms: I've experienced vestibular and hearing loss in my right ear (previously only left was affected). I have reported this as a possible adverse event due to the timing
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Balance disorder | ✓ | ✓ | ✓ |
| SD | Deafness | ✓ | ✓ | ✓ |
| SD | Exposure to SARS-CoV-2 | ✓ | ✓ | ✓ |
| SD | Hypoacusis | ✓ | ✓ | ✓ |
| SD | Labyrinthitis | ✓ | ✓ | ✓ |
| SD | Vestibular disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release